Termination Agreement is entered into by and between Core F.G. Co. Ltd. ("CFG"),
Rexahn Pharmaceuticals ("Rexahn"), Inc. and Future System, Inc. ("FSI")
(collectively referred to as the "Parties") on this 7 day of June, 2006, with
regard to the Management Agreement, Share Subscription Agreement, and
Intellectual Property Assignment & License Agreement (collectively referred
to as the "Agreements") entered into by and between the Parties on 19 day of
Parties now desire to provide for the termination of the Agreements entered
by and between the Parties on 19 day of April, 2006, and agree as
Parties agree and acknowledge that all or any rights and obligations under
Agreements and any other agreements, written or oral, executed by the Parties
the course of negotiating the Agreements, have been terminated pursuant to
rejection of proposed transactions at FSI's shareholder's meeting held on the
7th day of June, 2006.
Parties hereby release, discharge and waive any claims, whether civil, criminal
or any other complaints, against each other arising out or in any way connected
with the termination of the Agreements.
Parties agree and acknowledge confirm that each party shall bear its own costs
and expenses incurred in relation to the execution and delivery of the
Agreements including but not limited to attorney fees, consulting services
and due diligence expenses.
F.G. Co. Ltd.:
Director /s/ Mr. In-Young Oh
Director /s/ Mr. Chang-Ho Ahn
Director /s/ Mr. Kwang-Tae Kim